Invesco’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,266
Closed -$57.1K 3917
2024
Q2
$57.1K Buy
+10,266
New +$36.5K ﹤0.01% 3809
2019
Q1
Sell
-1,008
Closed -$11K 3852
2018
Q4
$11K Buy
1,008
+111
+12% +$1.62K ﹤0.01% 3777
2018
Q3
$13K Sell
897
-136
-13% -$2.07K ﹤0.01% 3859
2018
Q2
$15K Buy
+1,033
New +$14.5K ﹤0.01% 3843
2015
Q3
Sell
-76
Closed -$5K 4024
2015
Q2
$5K Buy
+76
New +$5.24K ﹤0.01% 4225
2014
Q2
Sell
-24,071
Closed -$2.85M 4095
2014
Q1
$2.85M Buy
+24,071
New +$2.34M ﹤0.01% 2325

Invesco's ALIM Position: Q3 2024 in Review

Invesco sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 10,266 shares — an estimated $57.1K sold.

Invesco first reported a position in ALIM in Q1 2014 and held it in 6 quarters. The position peaked at $2.85M in Q1 2014. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

  • Invesco reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
  • Invesco sold 10,266 Alimera Sciences shares in Q3 2024, an estimated $57.1K.
  • Invesco first reported a position in Alimera Sciences in Q1 2014 and held it in 6 quarters.
  • Invesco's Alimera Sciences position peaked at $2.85M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Invesco's 13F filing for Q3 2024, filed 12 Nov 2024.